EGFR and lung carcinoma: For example, the overexpression and amplification of epidermal growth factor receptor (EGFR) [9], and the underexpression and loss of dual specificity phosphate 4 (DUSP4), correlate strongly with each other; where each serves as an effective prognostic biomarker in lung cancer [6].